Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Carla Mattos

Northeastern University, USA

Title: Allosteric modulation of the Ras active site: From biochemistry to binding specificity

Biography

Biography: Carla Mattos

Abstract

Ras is found mutated in about 20% of human cancers, associated with poor prognosis due to a lack of drugs able to deter uncontrolled signaling through multiple pathways in the cell. There are three isoforms: H-, K-, and N-Ras. The G-domain, which catalyzes GTP hydrolysis and mediates downstream signaling, is 95% conserved between the Ras proteins. To date, biochemical studies done on H-Ras have been considered representative of all three Ras proteins. We have recently shown, using a combination of X-ray crystallography, NMR spectroscopy, enzyme kinetic assays and molecular dynamics simulations, that the three isoforms are biochemically distinct due to allosteric effects of isoform-specific residues on the population of conformational states. Furthermore, oncogenic mutations also affect conformational states in the particular isoforms. An engineered high-affinity binder shows a modest specificity toward K-RasG12D over the wild type protein and crystal structures of the complexes reveal allosteric effects on conformational states induced by the mutation, providing a view of specificity features that may be further developed to direct targeting of oncogenic mutants of K-Ras.